Location History:
- Skiftevej, DK (1983)
- Gentofte, DK (1983 - 2015)
Company Filing History:
11 out of 1,777 
5 out of 103 
1 out of 10 Years Active: 1983-2015
Title: Innovator Spotlight: Lars Thim - Pioneering Advances in Hemophilia Treatment
Introduction
Lars Thim, a prolific inventor hailing from Gentofte, Denmark, is making waves in the field of hemophilia treatment with his groundbreaking patents. With a total of 18 patents to his name, Lars Thim is a distinguished figure in the realm of pharmaceutical innovations.
Latest Patents
Among Lars Thim's latest patents is the development of Conjugated Factor VIII molecules. This innovation involves B-domain truncated Factor VIII molecules that have a modified circulatory half-life, achieved through covalent conjugation with a hydrophilic polymer. These molecules hold promise for enhancing the treatment efficacy of hemophilia. Additionally, Lars Thim has also patented compounds suitable for the treatment of blood clotting diseases, specifically Von Willebrand (VWF) compounds, and compositions that incorporate both Factor VIII molecules and VWF compounds.
Career Highlights
Lars Thim has contributed his expertise to renowned companies such as Novo Nordisk A/S and Novo Industri A/S. His tenure at these organizations has been marked by a relentless pursuit of cutting-edge pharmaceutical solutions for hemophilia management. Lars Thim's dedication to research and development has led to the successful translation of innovative ideas into patented technologies that have the potential to transform hemophilia treatment paradigms.
Collaborations
Throughout his career, Lars Thim has collaborated closely with esteemed colleagues such as Ole Hvilsted Olsen and Kjeld Norris. These collaborative efforts have not only fostered a culture of innovation but have also facilitated the exchange of ideas and expertise in the pursuit of advancing hemophilia therapeutics. Lars Thim's collaborative spirit underscores his commitment to driving progress in the pharmaceutical landscape.
Conclusion
In conclusion, Lars Thim's pioneering work in the field of hemophilia treatment illuminates his status as a visionary inventor. His string of patents, including the development of novel Factor VIII molecules and VWF compounds, exemplifies his innovative prowess and dedication to revolutionizing patient care in hematology. Lars Thim's contributions stand as a testament to the transformative power of innovation in the realm of pharmaceuticals, offering hope for improved treatment modalities for individuals with hemophilia.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.